Pharma company Teva to pay $27 million over charges of kickbacks to promote dangerous antipsychotic

Share this article:

Teva Pharmaceuticals and subsidiary IVAX LLC have agreed to a $27.6 million settlement over charges that they paid kickbacks to a psychiatrist for putting nursing home residents on the antipsychotic drug clozapine, the U.S. Department of Justice announced Tuesday.

IVAX allegedly paid a $50,000 “consulting fee” to Chicago physician Michael J. Reinstein, M.D., in exchange for the doctor putting nursing home patients on the generic clozapine made by the company, according to the federal authorities. IVAX also allegedly provided other perks and payments over several years, during which time Reinstein became the No. 1 prescriber of generic clozapine in the country. Teva acquired IVAX in 2005, two years after prosecutors say the kickback arrangement began.

Clozapine poses potentially deadly risks for elderly patients, including a diminished white blood cell count. By 2009, at least three of Reinstein's patients had died of clozapine intoxication, according to an investigation by ProPublica and the Chicago Tribune.

A civil lawsuit against Reinstein is pending in the Northern District of Illinois. He filed at least 140,000 false claims for clozapine in the course of prescribing the drug unnecessarily to “thousands” of nursing home residents, the U.S. attorney charged.

Neither Pennsylvania-based Teva nor Florida-based IVAX has admitted any wrongdoing, and the settlement does not assign liability to either company, according to the DOJ. Teva had not responded to a call from McKnight's as of press time.
Share this article:

More in News

Bill addressing admission status receives praise

A bill that would require hospitals to give patients a formal notice of their admission status has received strong support from healthcare associations.

Increased 'bed taxes' on nursing facilities warrant stricter federal oversight, report states

States have been increasingly taxing skilled nursing facilities and other healthcare providers to fund Medicaid in recent years, and federal authorities should look more closely at this trend, according to a government report released Tuesday.

Last chance: Tech Awards deadline arrives

Last chance: Tech Awards deadline arrives

There are hours left for innovative long-term care providers to enter the third annual McKnight's Excellence in Technology Awards. Submissions will be accepted until the stroke of midnight tonight.